PGNY
Progyny Inc

2,403
Loading...
Loading...
News
all
press releases
Surging Earnings Estimates Signal Upside for Progyny (PGNY) Stock
Progyny (PGNY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Zacks·23d ago
News Placeholder
More News
News Placeholder
CVS Health Corporation (CVS) Hit a 52 Week High, Can the Run Continue?
CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks·23d ago
News Placeholder
Progyny (PGNY) Tops Q2 Earnings and Revenue Estimates
Progyny (PGNY) delivered earnings and revenue surprises of +9.09% and +3.22%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Agilon Health (AGL) Reports Q2 Loss, Misses Revenue Estimates
Agilon (AGL) delivered earnings and revenue surprises of -127.27% and -4.98%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
BrightSpring Health Services, Inc. (BTSG) Q2 Earnings and Revenues Beat Estimates
BrightSpring Health Services, Inc. (BTSG) delivered earnings and revenue surprises of +15.79% and +5.40%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Progyny (PGNY) Earnings Expected to Grow: Should You Buy?
Progyny (PGNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·2mo ago
News Placeholder
Will Progyny (PGNY) Beat Estimates Again in Its Next Earnings Report?
Progyny (PGNY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks·2mo ago
News Placeholder
Strength Seen in Progyny (PGNY): Can Its 13.2% Jump Turn into More Strength?
Progyny (PGNY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks·3mo ago
News Placeholder
Teladoc (TDOC) Moves 14.4% Higher: Will This Strength Last?
Teladoc (TDOC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Zacks·3mo ago
News Placeholder
Strength Seen in Brainsway (BWAY): Can Its 5.3% Jump Turn into More Strength?
Brainsway (BWAY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Zacks·3mo ago

Latest PGNY News

View

Advertisement. Remove ads.

Advertisement. Remove ads.